Preamble 1
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council ( 1 ) , and in particular Article 14, in conjunction with Article 17 thereof,
Whereas:
HAS ADOPTED THIS REGULATION:
recital 1recital 1
(1) In accordance with Regulation (EC) No 470/2009, the Commission is to establish, by way of a Regulation, maximum residue limits (‘MRLs’) for pharmacologically active substances intended for use in the Union in veterinary medicinal products for food-producing animals or in biocidal products used in animal husbandry.
recital 2recital 2
(2) Table 1 of the Annex to Commission Regulation (EU) No 37/2010 ( 2 ) sets out the pharmacologically active substances and their classification regarding MRLs in foodstuffs of animal origin.
recital 3recital 3
(3) Praziquantel is already included in that table as an allowed substance for ovine and equidae species. The existing entry has a ‘no MRL required’ classification.
recital 4recital 4
(4) In accordance with Article 3 of Regulation (EC) No 470/2009, on 27 July 2021, VETHELLAS AEBE submitted a request to the European Medicines Agency (‘Agency’) for the extension of the existing entry for praziquantel to fin fish.
recital 5recital 5
(5) On 8 September 2022, the Agency, through the opinion of the Committee for Medicinal Products for Veterinary Use, concluded that the establishment of an MRL for praziquantel in fin fish, in relation to muscle and skin in natural proportions, was appropriate.
recital 6recital 6
(6) In accordance with Article 5 of Regulation (EC) No 470/2009, the Agency is to consider using MRLs established for a pharmacologically active substance in a particular foodstuff for another foodstuff derived from the same species, or MRLs established for a pharmacologically active substance in one or more species for other species.
recital 7recital 7
(7) The Agency concluded that the extrapolation of the ‘no MRL required’ classification for praziquantel in ovine species to other ruminants, except cattle, is appropriate.
recital 8recital 8
(8) In view of the opinion of the Agency, the Commission considers it appropriate to establish an MRL for praziquantel in fin fish, in relation to muscle and skin in natural proportions and to establish the recommended ‘no MRL required’ classification for praziquantel in all ruminants except bovine species.
recital 9recital 9
(9) Regulation (EU) No 37/2010 should therefore be amended accordingly.
recital 10recital 10
(10) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,
Article 1
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
Article 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
Annex 1ANNEX
In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘praziquantel’ is replaced by the following:
Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Praziquantel NOT APPLICABLE All ruminants except bovine, Equidae No MRL required NOT APPLICABLE NO ENTRY NO ENTRY Praziquantel (sum of isomers) Fin fish 20 μg/kg Muscle and skin in natural proportions NO ENTRY NO ENTRY’